+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Four residues of the extracellular N-terminal domain of the NR2A subunit control high-affinity Zn2+ binding to NMDA receptors



Four residues of the extracellular N-terminal domain of the NR2A subunit control high-affinity Zn2+ binding to NMDA receptors



Neuron 25(3): 683-694



NMDA receptors are allosterically inhibited by Zn2+ ions in a voltage-independent manner. The apparent affinity for Zn2+ of the heteromeric NMDA receptors is determined by the subtype of NR2 subunit expressed, with NR2A-containing receptors being the most sensitive (IC50, approximately 20 nM) and NR2C-containing receptors being the least sensitive (IC50, approximately 30 microM). Using chimeras constructed from these two NR2 subtypes, we show that the N-terminal LIVBP-like domain of the NR2A subunit controls the high-affinity Zn2+ inhibition. Mutations at four residues in this domain markedly reduce Zn2+ affinity (by up to >500-fold) without affecting either receptor activation by glutamate and glycine or inhibition by extracellular protons and Ni2+ ions, indicating that these residues most likely participate in high-affinity Zn2+ binding.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 010679977

Download citation: RISBibTeXText

PMID: 10774735

DOI: 10.1016/s0896-6273(00)81070-3


Related references

The NR2A subunit of recombinant NR1/NR2A NMDA receptors contains putative glutamate binding residues. Society for Neuroscience Abstracts 23(1-2): 1391, 1997

Identification of Amino Acid Residues of the Nr2A Subunit That Control Glutamate Potency in Recombinant Nr1/Nr2A Nmda Receptors. The Journal of Neuroscience 18(2): 581-589, 1998

Identification of amino acid residues of the NR2A subunit that control glutamate potency in recombinant NR1/NR2A NMDA receptors. Journal of Neuroscience 18(2): 581-589, 1998

Identification of residues important for high affinity zinc inhibition of NR1-NR2A NMDA receptors. Society for Neuroscience Abstracts 25(1-2): 1715, 1999

An endoplasmic reticulum retention signal located in the extracellular amino-terminal domain of the NR2A subunit of N-Methyl-D-aspartate receptors. Journal of Biological Chemistry 284(30): 20285-20298, 2009

The high affinity zinc inhibition of NMDA NR1-NR2A receptors imposes a reevaluation of the NR2A-specific fast and reversible redox modulation. Society for Neuroscience Abstracts 23(1-2): 932, 1997

Structural requirements for high-affinity heparin binding: alanine scanning analysis of charged residues in the C-terminal domain of human extracellular superoxide dismutase. Biochemistry (American Chemical Society) 41(9): 68-75, 2002

The serine protease plasmin cleaves the N-terminal domain of the NR2A subunit of the NMDA receptor. Society for Neuroscience Abstracts 27(2): 2306, 2001

Assessing the function of the C-terminal domain of the NMDA receptor subunit NR2A by gene targeting. Society for Neuroscience Abstracts 20(1-2): 726, 1994

AlphaCaMKII binding to the C-terminal tail of NMDA receptor subunit NR2A and its modulation by autophosphorylation. Febs Letters 456(3): 394-398, 1999

High-affinity zinc inhibition of NMDA NR1-NR2A receptors. Journal of Neuroscience 17(15): 5711-5725, 1997

Mapping the high-affinity binding domain of 5-substituted benzimidazoles to the proximal N-terminus of the GluN2B subunit of the NMDA receptor. British Journal of Pharmacology 159(2): 449-461, 2010

Single-channel analysis of a point mutation of a conserved serine residue in the S2 ligand-binding domain of the NR2A NMDA receptor subunit. Journal of Physiology 574(Pt 2): 477-489, 2006

High-affinity binding to the GM-CSF receptor requires intact N-glycosylation sites in the extracellular domain of the beta subunit. Blood 95(11): 3357-3362, 2000

The serine protease plasmin cleaves the amino-terminal domain of the NR2A subunit to relieve zinc inhibition of the N-methyl-D-aspartate receptors. Journal of Biological Chemistry 284(19): 12862-12873, 2009